Bcl-2 overexpression in human breast cancer is reported to be associated with the presence of estrogen receptors (ER), small tumor size, low tumor grade, and a favorable prognosis [10-17], despite contradictory results [18,19]. This evidence concerns the gene BCL2 and breast carcinoma.